Key Insights

Highlights

Treatment Research

2 treatments under study, led by Jt1

Related Conditions

Often studied with 4 related conditions

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 100/100

Termination Rate

50.0%

1 terminated out of 2 trials

Success Rate

0.0%

-86.6% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

0

Data Visualizations

Phase Distribution

2Total
Not Applicable (1)
Phase 2/3 (1)

Trial Status

Terminated1
Withdrawn1

Clinical Trials (2)

Showing 2 of 2 trials
NCT05331222Not ApplicableTerminated

Proof-of-Concept Interventional Study With a Nasal Spray of JT-1 in Patients With Chronic Rhinitis or Chronic Sinusitis

NCT03519061Phase 2/3Withdrawn

Impact of Budesonide Irrigations on Patients With Chronic Rhinosinusitis and Impact on Sinus Surgery Rates

Showing all 2 trials

Research Network

Common Treatments

  • Jt11
  • Budesonide1

Active Sponsors

  • Jantar GmbH1
  • Kaiser Permanente1

Top Investigators

Related Conditions

  • Chronic Sinusitis1
  • Chronic Rhinitis1
  • Chronic Sinusitis Ethmoidal Posterior1
  • Chronic Sinus Infection1

Activity Timeline